ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

GAO Report Refutes Charges Against Control Program

May 30, 1980

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991

ACS announces 415 New Awards

August 31, 1979

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976